A meta-analysis on the efficacy of ticagrelor monotherapy after 3 months of dual antiplatelet therapy vs ticagrelor plus aspirin dual therapy on patients with ACS who underwent PCI

Back

ESC Professional Premium Access

A meta-analysis on the efficacy of ticagrelor monotherapy after 3 months of dual antiplatelet therapy vs ticagrelor plus aspirin dual therapy on patients with ACS who underwent PCI

Session: Pharmacology in coronary artery disease

Topic: Pharmacotherapy

Speaker: Doctor L. Galera (Manila, PH)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Loralie Galera

Manila Doctors Hospital, Manila (Philippines)

0 follower

6 more presentations in this session

Optimal antiplatelet therapy for patients after antiplatelet therapy-induced gastrointestinal bleeding: when to resume?

Speaker: Professor R. Huang (Beijing, CN)

Efficacy and safety of under-dose non-vitamin K antagonist oral anticoagulant with atrial fibrillation undergoing PCI: Insights from a nationwide population-based cohort study

Speaker: Ms G. Youk (Busan, KR)

Interplay among proton pump inhibitors, platelet reactivity and CYP2C19 genotyping in clopidogrel-treated patients after drug-eluting stent implantation

Speaker: Assistant Professor J. Kim (Seoul, KR)

Effectiveness and tolerability of trimetazidine 80mg once daily in patients with chronic coronary syndrome: the V-GOOD observational study

Speaker: Professor L. Wolff Gowdak (Sao Paulo, BR)

Bailout inclisiran-based triple lipid-lowering therapy reduces plaque lipid content in stable coronary artery disease patients

Speaker: Associate Professor K. Trusinskis (Riga, LV)

Access the full session

Pharmacology in coronary artery disease

Speakers: Doctor L. Galera, Professor R. Huang, Ms G. Youk, Assistant Professor J. Kim, Professor L. Wolff Gowdak...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

A meta-analysis on the efficacy of ticagrelor monotherapy after 3 months of dual antiplatelet therapy vs ticagrelor plus aspirin dual therapy on patients with ACS who underwent PCI

About the speaker

Doctor Loralie Galera

6 more presentations in this session

Optimal antiplatelet therapy for patients after antiplatelet therapy-induced gastrointestinal bleeding: when to resume?

Efficacy and safety of under-dose non-vitamin K antagonist oral anticoagulant with atrial fibrillation undergoing PCI: Insights from a nationwide population-based cohort study

Interplay among proton pump inhibitors, platelet reactivity and CYP2C19 genotyping in clopidogrel-treated patients after drug-eluting stent implantation

Effectiveness and tolerability of trimetazidine 80mg once daily in patients with chronic coronary syndrome: the V-GOOD observational study

Bailout inclisiran-based triple lipid-lowering therapy reduces plaque lipid content in stable coronary artery disease patients

Access the full session

Pharmacology in coronary artery disease

About the event

ESC Congress 2023

ESC 365 is supported by